Skip to content

Effects of the general anesthetic technique of sevoflurane of sub-anesthesia concentration combined with remifentanil on recovery and cognitive function after laparoscopic gastric cancer surgery: a randomized controlled trial

Effects of the general anesthetic technique of sevoflurane of sub-anesthesia concentration combined with remifentanil on recovery and cognitive function after laparoscopic gastric cancer surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021964
Enrollment
Unknown
Registered
2019-03-18
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric neoplasms requiring laparoscopic surgery

Interventions

experimental group T:maintained at a sevoflurane minimum alveolar concentration (MAC) of 0.8±0.1 during the operation.
routine method group C1:routine concentration of sevoflurane
routine method group C2:propofol total intravenous anesthesia

Sponsors

Department of Anesthesiology, Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients scheduled for elective laparoscopic gastric cancer resection. (2) American Society of Anesthesiologists physical staus?-?. (3) Operative time 3h-6h. (4) Age 65-80 years. (5) One day before operation, the (MMSE) score of Mini-mental State Examination was given and the score was = 24. (6) The education level was not less than 6 years. (7) Every patient provided written informed consent.

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria will not participate in this study. 1, A long history of taking a large amount of sedative drugs or antidepressants and antianxiety drugs. 2. A history of serious cardiovascular and cerebrovascular diseases and impaired liver and kidney functions. 3. Having an immune system, central nervous system disease, or mental illness. 4. History of severe drug dependence and alcohol abuse . 5. Anaesthesia in the past 3 months, history of surgery. 6. Patients with severe hearing, visual impairment or other reasons can not communicate with the visitor. 7. Patients who are not compliant or unable to communicate with the preoperative test, and could not complete the follow-up after operation. 8. Preoperative biochemical examination suggested renal dysfunction (serum creatinine > 177 µmol/L) or active liver disease. 9. Patients who have had a history of brain surgery. 10. The patient has a history of being sensitive or allergic to the drugs used in this study. 11. The actual weight of the patient was more than ±25% of the standard weight.

Design outcomes

Primary

MeasureTime frame
Time of eye opening and extubation recorded after operation;MMSE and TMT;

Countries

China

Contacts

Public ContactJiebo Wang

Department of Anesthesiology, Fujian Medical University Union Hospital

258960368@qq.com+86 15959004325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026